Article Details

Ajinomoto and Bright Peak partner to develop immunocytokines

Retrieved on: 2021-04-01 08:03:45

Tags for this article:

Click the tags to see associated articles and topics

Ajinomoto and Bright Peak partner to develop immunocytokines. View article details on hiswai:

Excerpt

... told BioPharma-Reporter how this works: “Our AJICAP technology uses a certain peptide derivative that has a binding affinity to a specific region in ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up